1 Investor Relations │ Q4 2022 Results Company overview Financial review 2023 priorities Appendix | --- | --- | --- | --- | --- | --- | --- | |-----------------------|-------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | Q4 2022 Results | | | | | | | | Investor presentation | | | | | | | | | | | | | | | U NOVARTIS | Reimagining Medicine ← Company overview Financial review 2023 priorities Appendix 2 NOVARTIS Q4 RESULTS | FEBRUARY 1, 2023 | NOVARTIS INVESTOR PRESENTATION Disclaime ...